ID A0A4P8DKN2_HUMAN Unreviewed; 365 AA. AC A0A4P8DKN2; DT 31-JUL-2019, integrated into UniProtKB/TrEMBL. DT 31-JUL-2019, sequence version 1. DT 14-DEC-2022, entry version 6. DE SubName: Full=DNA repair-associated BRCA2 {ECO:0000313|EMBL:QCL11117.1}; GN Name=BRCA2 {ECO:0000313|EMBL:QCL11117.1}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606 {ECO:0000313|EMBL:QCL11117.1}; RN [1] {ECO:0000313|EMBL:QCL11117.1} RP NUCLEOTIDE SEQUENCE. RA Kwong A., Shin V.Y., Law F.B.F., Au T., Ho C.Y.S., Chan C.T.L., Ma E.S.K.; RT "Full spectrum of BRCA1 and BRCA2 deleterious mutations in Hong Kong."; RL Submitted (OCT-2018) to the EMBL/GenBank/DDBJ databases. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; MK028704; QCL11117.1; -; mRNA. DR AlphaFoldDB; A0A4P8DKN2; -. DR PeptideAtlas; A0A4P8DKN2; -. DR ChiTaRS; BRCA2; human. DR GO; GO:0000724; P:double-strand break repair via homologous recombination; IEA:InterPro. DR InterPro; IPR015525; BRCA2. DR PANTHER; PTHR11289; BREAST CANCER TYPE 2 SUSCEPTIBILITY PROTEIN BRCA2; 1. PE 2: Evidence at transcript level; FT REGION 38..68 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" SQ SEQUENCE 365 AA; 41279 MW; 7A2A9B237874920E CRC64; MPIGSKERPT FFEIFKTRCN KADLGPISLN WFEELSSEAP PYNSEPAEES EHKNNNYEPN LFKTPQRKPS YNQLASTPII FKEQGLTLPL YQSPVKELDK FKLDLGRNVP NSRHKSLRTV KTKMDQADDV SCPLLNSCLS ESPVVLQCTH VTPQRDKSVV CGSLFHTPKF VKGRQTPKHI SESLGAEVDP DMSWSSSLAT PPTLSSTVLI VRNEEASETV FPHDTTANVK SYFSNHDESL KKNDRFIASV TDSENTNQRE AASHGFGKTS GNSFKVNSCK DHIGKSMPNV LEDEVYETVV DTSEEDSFSL CFSKCRTKNL QKVRTSKTRK KIFHEANADE CEKSKNQVKE NTHLYLKWNQ MILIH //